Remicade® Treatment Discontinuation and Associated Factors Among Patients With Crohn's Disease and Ulcerative Colitis in the US: 2012-2015

被引：0
|
作者：
Rosenthal, Ning [1 ]
Wu, David [2 ]
Arsever, Christiane [2 ]
Kartashov, Alex [1 ]
Baumer, Dorothy [1 ]
机构：
[1] Premier Inc, Charlotte, NC USA
[2] Merck & Co Inc, Kenilworth, NJ USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2786
引用
收藏
页码：S1548 / S1548
页数：1
相关论文
共 50 条
  • [21] Treatment and biologic maintenance-dosing patterns among pediatric patients with ulcerative colitis or Crohn's disease
    Hunter, Theresa
    Komocsar, Wendy J.
    Colletti, Richard B.
    Liu, Chunyan
    Benkov, Keith J.
    Dotson, Jennifer L.
    Steiner, Steven J.
    Zhang, Nanhua
    Crandall, Wallace
    Network, ImproveCareNow
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (01) : 63 - 69
  • [22] Infliximab dose intensification in patients with crohn's disease and ulcerative colitis: associated costs
    Taxonera, Carlos
    Olivares, David
    Mendoza, Juanl
    Caas, Mercedes
    Diaz-Rubio, Manuel
    Rey, Enrique
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 812 - 813
  • [23] Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications
    Hiroko Kunitake
    Richard Hodin
    Paul C. Shellito
    Bruce E. Sands
    Joshua Korzenik
    Liliana Bordeianou
    Journal of Gastrointestinal Surgery, 2008, 12 : 1730 - 1737
  • [24] Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications
    Kunitake, Hiroko
    Hodin, Richard
    Shellito, Paul C.
    Sands, Bruce E.
    Korzenik, Joshua
    Bordeianou, Liliana
    JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (10) : 1730 - 1736
  • [25] Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease
    Danilova, N. A.
    Abdulkhakov, S. R.
    Grigoryeva, T. V.
    Markelova, M. I.
    Vasilyev, I. Yu.
    Boulygina, E. A.
    Ardatskaya, M. D.
    Pavlenko, A. V.
    Tyakht, A. V.
    Odintsova, A. Kh.
    Abdulkhakov, R. A.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (04) : 13 - 20
  • [26] ANALYZING TRENDS IN MEDICAL EXPENDITURES ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) AMONG US ADULTS: 2012-2015
    Kharat, A.
    Li, W.
    Wu, W. K.
    VALUE IN HEALTH, 2019, 22 : S383 - S383
  • [27] Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis Patients
    Robertha, Biondi
    Mariana, Dorna
    Julio, Baima
    Rosemary, da Silva
    Gabriela, Batista
    Joao, Hueb
    Ligia, Sassaki
    Sergio Alberto, Rupp de Paiva
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S21 - S21
  • [28] Insurance risks for patients with ulcerative colitis or Crohn's disease
    Travis, SPL
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) : 51 - 59
  • [29] DISCONTINUATION OF CORTICOSTEROIDS AMONG ULCERATIVE COLITIS PATIENTS TREATED WITH VEDOLIZUMAB IN THE UNITED STATES (US)
    Patel, Haridarshan
    Chastek, Benjamin
    Null, Kyle D.
    Demuth, Dirk
    GASTROENTEROLOGY, 2017, 152 (05) : S396 - S397
  • [30] Diagnosis of lymphocytic or collagenous colitis in patients with ulcerative colitis or Crohn's disease
    Panaccione, R
    Tremaine, WJ
    Batts, KW
    Sandborn, WJ
    GASTROENTEROLOGY, 1999, 116 (04) : A833 - A833
12345